Discontinued — last reported Q3 '16

Other

Partners Capital

Medline, Inc. Partners Capital increased by 2.3% to $16.87B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.4%, from $16.16B to $16.87B. Over 3 years (FY 2022 to FY 2025), Partners Capital shows relatively stable performance with a 0.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityStable
First reportedQ4 2014
Last reportedQ3 2016

How to read this metric

Growth in partners' capital generally indicates successful operations and the retention of earnings within the business.

Detailed definition

This represents the total equity interest of all partners in the partnership, including both general and limited partner...

Peer comparison

Equivalent to 'Total Shareholders' Equity' for corporations, but specific to the partnership structure.

Metric ID: other_partners_capital

Historical Data

5 periods
 Q4 '22Q4 '23Q4 '24Q1 '25Q4 '25
Value$16.62B$16.74B$16.16B$16.49B$16.87B
QoQ Change+0.7%-3.5%+2.1%+2.3%
YoY Change+0.7%-3.5%+4.4%
Range$16.16B$16.87B
CAGR+1.5%
Avg YoY Growth+0.6%
Median YoY Growth+0.7%
Current Streak2 quarters growth

Frequently Asked Questions

What is Medline, Inc. 's partners capital?
Medline, Inc. (MDLN) reported partners capital of $16.87B in Q4 2025.
How has Medline, Inc. 's partners capital changed year-over-year?
Medline, Inc. 's partners capital increased by 4.4% year-over-year, from $16.16B to $16.87B.
What is the long-term trend for Medline, Inc. 's partners capital?
Over 3 years (2022 to 2025), Medline, Inc. 's partners capital has grown at a 0.5% compound annual growth rate (CAGR), from $16.62B to $16.87B.
What does partners capital mean?
The total equity value belonging to all partners in the partnership.